Michael Cronquist Christensen, DrPH
H. Lundbeck A/S, Valby, Denmark; Corresponding author: Michael Cronquist Christensen, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark ([email protected]).
Original Research
Vortioxetine vs Desvenlafaxine in Patients With MDD
May 22, 2023
Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
Original Research
Vortioxetine and Cognition in Working Patients With MDD
January 25, 2017
Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...
